PTPRC and neoplasm: While one study [52] reported no difference in the presence of CD45+ immune cells between SCC and AC, the majority of studies suggested a distinct immune landscape in SCC, with Rotman et al. [17] reporting a higher ratio of infiltrating CD45+ immune cells relative to EpCAM+ tumour cells in SCC.